Antimicrobial Resistant Microorganisms

PRODUCT SPOTLIGHT Page 1 Credible leads to Incredible® A G LOBA L HE A LT H T HRE AT Antimicrobial resistance is one of the greatest global health threats affecting humanity. The emergence and spread of antimicrobial-re- sistant microorganisms affects our ability to treat common infections, progress in healthcare, and survival from routine surgeries. ANTIMICROBIAL-RESISTANT MICROORGANISMS T OGE T HER WE C AN F I ND A S OLU T I ON ATCC understands the danger and growing concern behind the spread of antimicrobial resistance. To aid research focused on the preven- tion and treatment of infections caused by antimicrobial-resistant microorganisms, ATCC has acquired and authenticated various clinical strains of interest, including: Carbapenem-resistant Acinetobacter Candida auris Clostridioides difficile Carbapenem-resistant Enterobacterales Drug-resistant Neisseria gonorrhoeae Drug-resistant Campylobacter Drug-resistant Candida ESBL-producing Enterobacterales Vancomycin-resistant Enterococci (VRE) Multidrug-resistant Pseudomonas aeruginosa Drug-resistant nontyphoidal Salmonella Drug-resistant Salmonella serotype Typhi Methicillin-resistant Staphylococcus aureus (MRSA) Drug-resistant Streptococcus pneumoniae Drug-resistant Mycobacterium tuberculosis Erythromycin-resistant Group A Streptococcus 2.8 million+ infections 35 thousand+ deaths $4.6B+ in costs to treat infections caused by 6 of the 18 most alarming drug- resistant germs ANTIBIOTIC RESISTANCE ESTIMATES IN THE UNITED STATES PER YEAR Centers for Disease Control and Prevention, National Infection & Death Estimates for Antimicrobial Resistance